Table 1. Comparison of clinical parameters, miRNAs levels and 25-hydroxyvitamin D status between cases and controls.
SLE cases | Healthy controls | P | |||
---|---|---|---|---|---|
Mean | SD | Mean | SD | ||
Total subjects (n) | 42 | 48 | |||
Male (n) | 3 | 4 | 1.000 | ||
Female (n) | 39 | 44 | |||
Age (years) | 36.19 | 11.72 | 35.04 | 10.77 | 0.629 |
BMI (kg/m2) | 20.94 | 2.29 | 20.86 | 2.81 | 0.892 |
Vitamin D (nmol/L) | 41.69 | 12.81 | 62.58 | 12.34 | 0.000 |
miRNA-410 | 0.0349 | 0.0262 | 0.1127 | 0.1429 | 0.001 |
miRNA-377 | 0.0007 | 0.0008 | 0.0046 | 0.0071 | 0.000 |
miRNA-342 | 73.3424 | 52.9918 | 649.02731 | 156.7059 | 0.001 |
miRNA-10a | 0.0037 | 0.0041 | 0.0236 | 0.2987 | 0.000 |
miRNA-374b | 3.9956 | 2.8982 | 37.0733 | 20.5389 | 0.000 |
miRNA-125a | 0.0338 | 0.0224 | 0.1214 | 0.1799 | 0.002 |